Stock NURO NEUROMETRIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials NeuroMetrix, Inc.

Equities

NURO

US6412558800

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
4.44 USD +0.68% Intraday chart for NeuroMetrix, Inc. +2.54% +23.33%
Apr. 19 Sector Update: Health Care Stocks Advance Late Afternoon MT
Apr. 19 Sector Update: Health Care Stocks Rise Friday Afternoon MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5.597 4.206 11.96 33.51 11.56 3.866
Enterprise Value (EV) 1 -1.183 2.585 7.794 11.47 -9.286 -13.89
P/E ratio 380 x -1.1 x -4.55 x -11.2 x -2.41 x -0.57 x
Yield - - - - - -
Capitalization / Revenue 0.35 x 0.45 x 1.62 x 4.06 x 1.4 x 0.66 x
EV / Revenue -0.07 x 0.28 x 1.06 x 1.39 x -1.12 x -2.35 x
EV / EBITDA 0.1 x -0.29 x -4.71 x -5.2 x 1.98 x 1.96 x
EV / FCF 0.21 x -0.43 x -6.88 x -10.6 x 2.36 x 3.74 x
FCF Yield 471% -231% -14.5% -9.46% 42.3% 26.7%
Price to Book 0.92 x 2.38 x 2.28 x 1.44 x 0.5 x 0.27 x
Nbr of stocks (in thousands) 92.1 122 473 834 970 1,074
Reference price 2 60.80 34.40 25.28 40.16 11.92 3.600
Announcement Date 1/24/19 1/28/20 1/29/21 1/28/22 3/22/23 3/1/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 16.09 9.273 7.378 8.253 8.256 5.901
EBITDA 1 -12.12 -8.79 -1.655 -2.208 -4.692 -7.096
EBIT 1 -12.29 -8.914 -1.745 -2.285 -4.742 -7.152
Operating Margin -76.39% -96.13% -23.65% -27.68% -57.43% -121.18%
Earnings before Tax (EBT) 1 0.0236 -3.773 -2.092 -2.281 -4.417 -6.529
Net income 1 0.0236 -3.773 -2.092 -2.281 -4.417 -6.529
Net margin 0.15% -40.69% -28.36% -27.64% -53.5% -110.64%
EPS 2 0.1600 -31.20 -5.552 -3.571 -4.955 -6.270
Free Cash Flow 1 -5.567 -5.961 -1.133 -1.086 -3.931 -3.714
FCF margin -34.6% -64.29% -15.36% -13.15% -47.61% -62.93%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 1/24/19 1/28/20 1/29/21 1/28/22 3/22/23 3/1/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 6.78 1.62 4.17 22 20.8 17.8
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -5.57 -5.96 -1.13 -1.09 -3.93 -3.71
ROE (net income / shareholders' equity) 0.42% -87.5% -53.8% -16% -19% -30.1%
ROA (Net income/ Total Assets) -70.8% -53.4% -14.6% -8.68% -12% -19.4%
Assets 1 -0.0334 7.072 14.28 26.27 36.93 33.67
Book Value Per Share 2 66.10 14.50 11.10 27.80 24.00 13.20
Cash Flow per Share 2 73.50 17.90 11.00 27.00 4.370 1.140
Capex 1 0.14 0.05 - 0.13 0.02 0.18
Capex / Sales 0.89% 0.52% - 1.6% 0.28% 3.11%
Announcement Date 1/24/19 1/28/20 1/29/21 1/28/22 3/22/23 3/1/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
NEUROMETRIX, INC. Stock NeuroMetrix, Inc.
+23.33% 8.82M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. NURO Stock
  4. Financials NeuroMetrix, Inc.